Brinzolamide
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01194 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 20 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | primary hereditary glaucoma | KG + DL |
| 2 | glaucoma 1, open angle | KG + DL |
| 3 | glaucoma | KG + DL |
| 4 | open angle glaucoma | KG + DL |
| 5 | closed-angle glaucoma | KG + DL |
| 6 | hydrophthalmos | KG + DL |
| 7 | commissural lip fistula | KG + DL |
| 8 | osteoradionecrosis of the mandible | KG + DL |
| 9 | oral leukoedema | KG + DL |
| 10 | burning mouth syndrome | KG + DL |
| 11 | oral candidiasis | KG + DL |
| 12 | congenital glaucoma | KG + DL |
| 13 | Axenfeld anomaly | KG + DL |
| 14 | angle-closure glaucoma | KG + DL |
| 15 | aqueous misdirection | KG + DL |
| 16 | traumatic glaucoma | KG + DL |
| 17 | glaucomatous atrophy of optic disc | KG + DL |
| 18 | neovascular glaucoma | KG + DL |
| 19 | salivary gland disease | KG + DL |
| 20 | tongue disease | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.